Alopecia Clinical Trials 2024

Alopecia research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in alopecia clinical trials today.

Popular Trials

Vasodilator

Oral Minoxidil for Hair Loss in Childhood Cancer Survivors

Recruiting0 awardsPhase 2

New York, New York

This trial will test if a drug can improve hair loss caused by cancer treatment in kids and young adults. Safety, dosing & quality of life will be monitored.

Procedure

PRP Therapy for Alopecia After Breast Cancer Treatment

Recruiting1 awardPhase < 1

New York, New York

This trial is testing a treatment for hair loss that involves injecting platelets from a person's own blood into their scalp.

Procedure

Fractional Photothermolysis for Alopecia

Recruiting1 awardPhase < 1

Irvine, California

This trial is being done to see if fractional photothermolysis using different lasers can help stimulate hair growth in people with scalp alopecia.

Procedure

Laser Treatment for Alopecia

Recruiting1 award2 criteria

New York, New York

"This trial is looking for healthy participants between the ages of 18 to 55 who have moderate hair loss and dark skin."

Cell Therapy

Autologous Adipose Cells Therapy for Hair Loss

Recruiting1 awardPhase 1 & 2

Lewes, Delaware

This trial aims to test a new treatment called Autologous Adipose Cell Therapy for improving skin and hair. It is designed to be safer and more effective than traditional fat grafting and dermal

Nutraceutical

Dietary Supplement for Hair Loss

Recruiting0 awards3 criteria

Phoenix, Arizona

This trial will test if a dietary supplement is safe and effective for men with hair thinning when taken for 9 months.

Popular Filters

Trials for Alopecia Areata Patients

Janus Kinase (JAK) Inhibitor

Baricitinib for Pediatric Hair Loss

Recruiting1 awardPhase 3

Birmingham, Alabama

This trial is testing baricitinib, a medication that may help treat severe hair loss. It targets children aged 6 to less than 18 years who have significant hair loss. The medication works by reducing the immune system's activity that causes hair loss.

JAK Inhibitor

PF-06651600 for Alopecia Areata

Recruiting2 awardsPhase 3

Birmingham, Alabama

This trial is testing a new drug to treat alopecia areata, which is an autoimmune disease that causes hair loss. The trial is open-label, which means all patients will receive the active drug. There is also a sub-study evaluating the immune response to vaccines in patients who have received the drug for at least 6 months.

Janus Kinase (JAK) Inhibitor

Ruxolitinib for Alopecia Areata

Recruiting1 awardPhase 2

Bethesda, Maryland

This trial tests if ruxolitinib, a pill that calms the immune system, can help people with APECED and severe hair loss. The medication works by blocking overactive immune signals, which may reduce body attacks and promote hair regrowth. Ruxolitinib has shown promise in treating severe alopecia areata by inducing hair regrowth in patients.

JAK Inhibitor

CTP-543 for Alopecia Areata

Recruiting1 awardPhase 2 & 3

Encinitas, California

This trial is testing CTP-543, a medication that may help people regrow hair by stopping the immune system from attacking hair follicles. It focuses on adults with chronic, moderate to severe alopecia areata. CTP-543 has shown promise in treating this condition.

Janus Kinase (JAK) Inhibitor

Baricitinib for Alopecia Areata

Recruiting0 awardsPhase 2 & 3

Birmingham, Alabama

This trial will help determine if baricitinib is an effective treatment for severe or very severe alopecia areata, and what the best dosage is.

Cellular Regenerative Treatment

Cell + Plasma Therapy for Hair Loss

Recruiting1 award8 criteria

Irvine, California

This trial is testing a new mixture of cells and plasma to see if it is safe and effective in treating hair loss. The mixture will be compared to a similar mixture and to a control group who will receive a standard treatment.

Trials for Male Pattern Baldness Patients

Nonablative Laser

Laser Therapy for Male Pattern Baldness and Scarring Alopecia

Recruiting1 award7 criteria

Elmsford, New York

This trialtested a laser to treat two types of hair loss: androgenetic & scarring alopecia.

Platelet-rich Plasma Therapy

Platelet-rich Plasma Therapy for Hair Loss

Recruiting1 awardPhase < 1

Winston-Salem, North Carolina

This trial will test whether a special blood product can help treat hair loss in women.

Neurotoxin

Botulinum Toxin for Androgenic Alopecia

Recruiting2 awardsPhase 2

Edina, Minnesota

This trial uses an injectable treatment known for reducing wrinkles to treat hereditary hair loss in adults. The injections are given in the scalp and may help improve hair growth by affecting muscles and blood flow.

Stem Cell Therapy

Exosomes + Microneedling for Male Pattern Baldness

Recruiting1 awardPhase 1

Brooklyn, New York

"This trial aims to find out if using stem cell-derived exosomes with microneedling on the scalp can help treat pattern hair loss, also known as Androgenetic Alopecia."

Topical Agent

PP405 for Male Pattern Baldness

Recruiting0 awardsPhase 2

Encinitas, California

This trial aims to confirm the safety findings from a previous trial and to understand the safety and how the drug is processed in the body over a longer period after 28 days of taking it.

Procedure

Robotic Hair Restoration for Male Pattern Baldness

Recruiting1 award5 criteria

San Jose, California

This trial will test a robotic system for hair restoration procedures at multiple clinics.

Phase 3 Trials

Janus Kinase (JAK) Inhibitor

Baricitinib for Pediatric Hair Loss

Recruiting1 awardPhase 3

Birmingham, Alabama

This trial is testing baricitinib, a medication that may help treat severe hair loss. It targets children aged 6 to less than 18 years who have significant hair loss. The medication works by reducing the immune system's activity that causes hair loss.

JAK Inhibitor

PF-06651600 for Alopecia Areata

Recruiting2 awardsPhase 3

Birmingham, Alabama

This trial is testing a new drug to treat alopecia areata, which is an autoimmune disease that causes hair loss. The trial is open-label, which means all patients will receive the active drug. There is also a sub-study evaluating the immune response to vaccines in patients who have received the drug for at least 6 months.

JAK Inhibitor

CTP-543 for Alopecia Areata

Recruiting1 awardPhase 2 & 3

Encinitas, California

This trial is testing CTP-543, a medication that may help people regrow hair by stopping the immune system from attacking hair follicles. It focuses on adults with chronic, moderate to severe alopecia areata. CTP-543 has shown promise in treating this condition.

Janus Kinase (JAK) Inhibitor

Baricitinib for Alopecia Areata

Recruiting0 awardsPhase 2 & 3

Birmingham, Alabama

This trial will help determine if baricitinib is an effective treatment for severe or very severe alopecia areata, and what the best dosage is.

Janus Kinase (JAK) Inhibitor

Upadacitinib for Severe Alopecia Areata

Recruiting1 awardPhase 3

Peterborough, Ontario

This trial is testing upadacitinib, a medication that may help people with severe hair loss due to alopecia areata. The drug works by stopping the immune system from attacking hair roots. Adolescents and adults with severe alopecia areata are participating to see if this treatment is safe and effective.

Anti-androgen

Clascoterone for Male Pattern Baldness

Recruiting1 awardPhase 3

North Little Rock, Arkansas

This trial aims to determine if Clascoterone can help men with male pattern hair loss. The study will compare Clascoterone solution to a placebo in two parts. In Part 1

Trials With No Placebo

Nutraceutical Supplement

Nutraceutical Supplements for Alopecia

Recruiting1 award

Sacramento, California

"This trial is a study at one location where they are testing hair supplements that are already on the market to see if they can help with thinning hair by addressing the main reasons for hair loss."

Scalp Cooling for Hair Loss in Breast Cancer

Recruiting1 award

San Francisco, California

This trial aims to determine if AMMA can help prevent hair loss in women with early-stage breast cancer who are undergoing chemotherapy.

Procedure

Mosaic Laser Treatment for Skin and Hair Conditions

Recruiting1 award5 criteria

Lincolnshire, Illinois

This trial is testing a laser treatment called the Mosaic Ultra 1550nm system. It aims to help people with skin problems like wrinkles, scars, and acne. The laser works by boosting the skin's natural healing process to make it look smoother and younger. The 1550 nm laser device has been previously studied for its safety and effectiveness in improving wrinkles, pigmentation, and skin texture.

Procedure

Cleansing Device for Scalp Conditions

Recruiting1 award10 criteria

Minneapolis, Minnesota

This trial will test whether an investigational WaterPik and brush device can improve scalp health.

Behavioural Intervention

Scalp Cooling for Chemotherapy-Induced Hair Loss

Recruiting1 award6 criteria

Bronx, New York

This trialis testing methods to improve scalp cooling efficacy in cancer patients with skin of color, to reduce chemotherapy-induced hair loss.

Behavioural Intervention

Cold Cap Therapy for Chemotherapy-Induced Hair Loss in Children

Recruiting1 award5 criteria

Memphis, Tennessee

This trial will test if the Paxman scalp cooling device is safe and effective in preventing hair loss in pediatric patients receiving chemotherapy for non-cancerous conditions or solid tumors.

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.